Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Miles D White. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Miles D White har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:CAT / Caterpillar Inc. | Director | 8 382 |
US:MCD / McDonald's Corporation | Director | 18 613 |
US:ABT / Abbott Laboratories | EXECUTIVE CHAIRMAN, Director | 3 092 852 |
US:MOT / | Director | 2 000 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Miles D White. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Miles D White som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-03-02 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −293 | 8 382 | −3,38 | 184,43 | −54 038 | 1 545 892 | |
2022-01-04 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 690 | 18 613 | 3,85 | 268,07 | 185 000 | 4 989 504 | |
2021-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −10 400 | 3 092 852 | −0,34 | ||||
2021-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −693 | 3 103 252 | −0,02 | ||||
2021-08-13 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 250 | 3 103 945 | −0,04 | ||||
2021-03-03 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −507 | 8 661 | −5,53 | ||||
2021-03-03 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 683 | 9 168 | 8,05 | ||||
2021-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −43 292 | 3 105 195 | −1,38 | 121,58 | −5 263 441 | 377 529 608 | |
2021-02-23 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 227 272 | 227 272 | |||||
2021-02-23 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 44 340 | 3 148 487 | 1,43 | ||||
2021-02-23 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −2 000 | 3 104 147 | −0,06 | ||||
2021-01-05 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 862 | 17 536 | 5,17 | 214,58 | 185 000 | 3 762 819 | |
2021-01-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 242 | 12 368 | 2,00 | 180,43 | 43 664 | 2 231 558 | |
2020-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 844 | 3 106 147 | −0,06 | ||||
2020-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −64 978 | 3 107 991 | −2,05 | ||||
2020-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −7 974 | 3 172 969 | −0,25 | ||||
2020-10-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 293 | 12 054 | 2,49 | 149,34 | 43 757 | 1 800 144 | |
2020-07-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 349 | 11 673 | 3,08 | 125,54 | 43 813 | 1 465 428 | |
2020-06-12 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 100 | 3 180 943 | −0,03 | ||||
2020-04-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 385 | 11 224 | 3,55 | 113,59 | 43 732 | 1 274 934 | |
2020-03-05 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −469 | 8 453 | −5,26 | 125,88 | −59 038 | 1 064 064 | |
2020-03-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −46 827 | 3 182 043 | −1,45 | 79,19 | −3 708 230 | 251 985 985 | |
2020-03-03 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 176 | 8 922 | 15,18 | ||||
2020-02-25 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 416 956 | 416 956 | |||||
2020-02-25 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 68 399 | 3 228 870 | 2,16 | ||||
2020-01-03 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 909 | 16 237 | 5,93 | 197,61 | 179 576 | 3 208 637 | |
2020-01-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 297 | 10 758 | 2,84 | 147,51 | 43 810 | 1 586 913 | |
2019-12-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −298 | 3 160 471 | −0,01 | ||||
2019-12-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −12 382 | 3 160 769 | −0,39 | ||||
2019-12-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −507 | 0 | −100,00 | ||||
2019-12-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 507 | 507 | |||||
2019-12-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 014 | 3 173 151 | −0,03 | ||||
2019-10-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 346 | 10 386 | 3,45 | 126,49 | 43 766 | 1 313 725 | |
2019-07-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 320 | 9 952 | 3,32 | 136,64 | 43 725 | 1 359 841 | |
2019-04-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 315 | 9 565 | 3,41 | 134,95 | 42 509 | 1 290 797 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −512 | 3 174 165 | −0,02 | 78,08 | −39 980 | 247 854 674 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 174 677 | 0,00 | 78,82 | −7 882 | 250 220 104 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 232 | 3 174 777 | −0,13 | 78,82 | −333 566 | 250 235 923 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −11 007 | 3 179 009 | −0,35 | 78,17 | −860 417 | 248 503 134 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 544 | 3 190 016 | −0,45 | 78,05 | −1 135 159 | 248 980 749 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 202 | 3 204 560 | −0,44 | 78,88 | −1 120 254 | 252 775 693 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −131 | 3 218 762 | 0,00 | 79,88 | −10 464 | 257 114 709 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −900 | 3 218 893 | −0,03 | 78,51 | −70 659 | 252 715 289 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 219 793 | −0,01 | 78,90 | −15 781 | 254 057 767 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 900 | 3 219 993 | −0,06 | 79,45 | −150 955 | 255 828 444 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 862 | 3 221 893 | −0,21 | 78,89 | −541 343 | 254 175 139 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −738 | 3 228 755 | −0,02 | 78,14 | −57 671 | 252 311 059 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −385 | 3 229 493 | −0,01 | 79,54 | −30 623 | 256 873 873 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 229 878 | −0,01 | 79,76 | −23 928 | 257 615 069 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 079 | 3 230 178 | −0,06 | 78,82 | −163 856 | 254 586 479 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 400 | 3 232 257 | −0,07 | 79,39 | −190 536 | 256 608 883 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −909 | 3 234 657 | −0,03 | 79,15 | −71 947 | 256 023 102 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 235 566 | 0,00 | 78,17 | −7 817 | 252 916 105 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 | 3 235 666 | 0,00 | 78,04 | −78 | 252 508 139 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 235 667 | 0,00 | 79,91 | −7 991 | 258 554 061 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 180 | 3 235 767 | −0,04 | 78,74 | −92 913 | 254 784 294 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 110 | 3 236 947 | −0,03 | 78,23 | −86 835 | 253 226 364 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 238 057 | −0,02 | 78,63 | −55 041 | 254 608 422 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 238 757 | −0,01 | 79,55 | −15 910 | 257 643 119 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 668 | 3 238 957 | −0,11 | 78,02 | −286 159 | 252 687 230 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 423 | 3 242 625 | −0,04 | 78,68 | −111 962 | 255 129 735 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 149 | 3 244 048 | −0,10 | 78,08 | −245 858 | 253 279 048 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 247 197 | 0,00 | 78,06 | −7 806 | 253 468 080 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 937 | 3 247 297 | −0,09 | 78,86 | −231 597 | 256 065 605 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −253 | 3 250 234 | −0,01 | 78,64 | −19 897 | 255 614 653 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 100 | 3 250 487 | −0,10 | 78,04 | −241 940 | 253 684 258 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 208 | 3 253 587 | −0,04 | 79,18 | −95 655 | 257 635 287 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −93 | 3 254 795 | 0,00 | 78,26 | −7 279 | 254 736 531 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 254 888 | −0,01 | 78,08 | −31 231 | 254 133 518 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 255 288 | −0,01 | 78,06 | −31 225 | 254 115 920 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 815 | 3 255 688 | −0,06 | 78,84 | −143 086 | 256 662 163 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 800 | 3 257 503 | −0,06 | 78,02 | −140 445 | 254 166 672 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 803 | 3 259 303 | −0,12 | 78,38 | −298 079 | 255 464 169 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 206 | 3 263 106 | −0,04 | 79,37 | −95 720 | 258 992 723 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 500 | 3 264 312 | −0,05 | 78,40 | −117 600 | 255 922 061 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 577 | 3 265 812 | −0,11 | 78,84 | −282 011 | 257 476 618 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 665 | 3 269 389 | −0,05 | 78,77 | −131 152 | 257 529 772 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 271 054 | −0,01 | 79,81 | −15 962 | 261 062 820 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 3 271 254 | −0,04 | 79,75 | −103 675 | 260 882 506 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 272 554 | −0,02 | 78,25 | −54 775 | 256 077 350 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 600 | 3 273 254 | −0,05 | 79,43 | −127 088 | 259 994 565 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 035 | 3 274 854 | −0,31 | 78,06 | −783 382 | 255 651 478 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 599 | 3 284 889 | −0,08 | 78,46 | −203 931 | 257 748 815 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 104 | 3 287 488 | −0,43 | 78,87 | −1 112 382 | 259 284 179 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 558 | 3 301 592 | −0,17 | 78,80 | −437 970 | 260 165 450 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 628 | 3 307 150 | −0,05 | 79,03 | −128 661 | 261 364 064 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −23 | 3 308 778 | 0,00 | 79,78 | −1 835 | 263 974 309 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −322 | 3 308 801 | −0,01 | 78,92 | −25 411 | 261 114 031 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 979 | 3 309 123 | −0,15 | 78,04 | −388 536 | 258 227 413 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 500 | 3 314 102 | −0,05 | 79,10 | −118 650 | 262 145 468 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 112 | 3 315 602 | −0,06 | 79,57 | −168 052 | 263 822 451 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 970 | 3 317 714 | −0,21 | 78,01 | −543 730 | 258 814 869 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 306 | 3 324 684 | −0,04 | 78,73 | −102 821 | 261 752 371 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 325 990 | −0,01 | 78,28 | −15 656 | 260 358 497 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 035 | 3 326 190 | −0,03 | 78,42 | −81 165 | 260 839 820 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 200 | 3 327 225 | −0,07 | 79,07 | −173 954 | 263 083 681 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 154 | 3 329 425 | −0,12 | 78,18 | −324 739 | 260 277 799 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 | 3 333 579 | 0,00 | 79,95 | −1 039 | 266 519 641 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 436 | 3 333 592 | −0,07 | 78,91 | −192 225 | 263 053 745 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 942 | 3 336 028 | −0,15 | 78,86 | −389 726 | 263 079 168 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 340 | 3 340 970 | −0,04 | 78,16 | −104 741 | 261 146 920 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 483 | 3 342 310 | −0,07 | 78,58 | −195 114 | 262 638 720 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −686 | 3 344 793 | −0,02 | 79,80 | −54 743 | 266 914 481 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 685 | 3 345 479 | −0,11 | 78,46 | −289 107 | 262 469 555 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 3 349 164 | −0,04 | 78,35 | −101 855 | 262 406 999 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 000 | 3 350 464 | −0,03 | 78,91 | −78 908 | 264 376 738 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −704 | 3 351 464 | −0,02 | 79,06 | −55 658 | 264 966 744 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 352 168 | −0,01 | 79,09 | −15 818 | 265 122 967 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | 1 100 | 3 352 368 | 0,03 | 79,56 | 87 516 | 266 714 398 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 600 | 3 353 468 | −0,05 | 78,49 | −125 584 | 263 213 703 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 330 | 3 355 068 | −0,19 | 78,08 | −494 246 | 261 963 709 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 361 398 | −0,01 | 78,56 | −39 280 | 264 071 427 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 925 | 3 361 898 | −0,06 | 78,02 | −150 188 | 262 295 282 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 037 | 3 363 823 | −0,18 | 79,49 | −479 881 | 267 390 290 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 369 860 | −0,01 | 79,50 | −39 750 | 267 903 870 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 499 | 3 370 360 | −0,10 | 78,88 | −275 984 | 265 837 145 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −900 | 3 373 859 | −0,03 | 79,27 | −71 343 | 267 445 803 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 100 | 3 374 759 | −0,09 | 79,46 | −246 326 | 268 158 350 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −11 900 | 3 377 859 | −0,35 | 78,00 | −928 260 | 263 489 891 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −504 | 3 389 759 | −0,01 | 78,74 | −39 682 | 266 892 675 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 400 | 3 390 263 | −0,07 | 79,40 | −190 560 | 269 186 882 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −877 | 3 392 663 | −0,03 | 79,47 | −69 695 | 269 614 929 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 807 | 3 393 540 | −0,05 | 78,26 | −141 416 | 265 578 440 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 523 | 3 395 347 | −0,40 | 78,00 | −1 054 794 | 264 837 066 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 | 3 408 870 | 0,00 | 78,70 | −157 | 268 295 113 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 | 3 408 872 | 0,00 | 79,06 | −79 | 269 522 465 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par valuef |
S - Sale | −1 800 | 3 408 873 | −0,05 | 79,18 | −142 524 | 269 914 564 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −36 669 | 3 410 673 | −1,06 | 78,06 | −2 862 382 | 266 237 134 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 447 342 | −0,01 | 78,64 | −23 590 | 271 081 738 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 447 642 | 0,00 | 79,71 | −7 971 | 274 811 544 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 800 | 3 447 742 | −0,17 | 78,66 | −456 228 | 271 199 386 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −75 | 3 453 542 | 0,00 | 78,20 | −5 865 | 270 049 717 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 816 | 3 453 617 | −0,05 | 78,84 | −143 183 | 272 300 432 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 800 | 3 455 433 | −0,05 | 78,93 | −142 074 | 272 737 327 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 3 457 233 | −0,04 | 79,08 | −102 804 | 273 397 986 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 458 533 | −0,01 | 79,68 | −23 904 | 275 575 909 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 891 | 3 458 833 | −0,17 | 78,47 | −462 267 | 271 414 626 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 701 | 3 464 724 | −0,19 | 78,76 | −527 771 | 272 881 662 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 471 425 | −0,01 | 78,36 | −39 180 | 272 020 863 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 094 | 3 471 925 | −0,18 | 78,80 | −480 177 | 273 570 330 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 044 | 3 478 019 | −0,09 | 79,02 | −240 537 | 274 833 061 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 481 063 | −0,01 | 79,41 | −15 882 | 276 431 213 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 100 | 3 481 263 | −0,03 | 79,59 | −87 549 | 277 073 722 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −570 | 3 482 363 | −0,02 | 79,65 | −45 400 | 277 370 213 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 482 933 | 0,00 | 79,40 | −7 940 | 276 562 295 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 275 | 3 483 033 | −0,09 | 78,72 | −257 808 | 274 184 358 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −20 | 3 486 308 | 0,00 | 79,52 | −1 590 | 277 248 644 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 100 | 3 486 328 | −0,06 | 78,50 | −164 850 | 273 676 748 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 181 | 3 488 428 | −0,09 | 78,10 | −248 420 | 272 428 785 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −16 700 | 3 491 609 | −0,48 | 78,86 | −1 317 046 | 275 365 744 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −265 | 3 508 309 | −0,01 | 78,58 | −20 822 | 275 665 380 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 800 | 3 508 574 | −0,05 | 78,44 | −141 201 | 275 230 087 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 611 | 3 510 374 | −0,30 | 78,09 | −828 613 | 274 125 106 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −16 200 | 3 520 985 | −0,46 | 79,91 | −1 294 542 | 281 361 911 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 200 | 3 537 185 | −0,06 | 78,30 | −172 260 | 276 961 586 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 802 | 3 539 385 | −0,05 | 78,46 | −141 385 | 277 700 147 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 357 | 3 541 187 | −0,07 | 78,88 | −185 932 | 279 346 536 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 110 | 3 543 544 | −0,06 | 79,19 | −167 091 | 280 613 249 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 678 | 3 545 654 | −0,10 | 79,14 | −291 077 | 280 603 058 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −140 | 3 549 332 | 0,00 | 78,16 | −10 942 | 277 398 042 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −509 | 3 549 472 | −0,01 | 78,78 | −40 102 | 279 645 152 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −420 | 3 549 981 | −0,01 | 79,25 | −33 285 | 281 335 994 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −531 | 3 550 401 | −0,01 | 78,72 | −41 798 | 279 469 815 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 223 | 3 550 932 | −0,03 | 78,78 | −96 348 | 279 742 423 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 900 | 3 552 155 | −0,05 | 79,16 | −150 404 | 281 188 590 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −687 | 3 554 055 | −0,02 | 78,48 | −53 912 | 278 904 466 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 282 | 3 554 742 | −0,20 | 78,14 | −569 015 | 277 767 540 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 562 024 | −0,01 | 79,38 | −23 814 | 282 753 465 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −18 702 | 3 562 324 | −0,52 | 78,07 | −1 460 065 | 278 110 635 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 581 026 | −0,01 | 79,60 | −23 880 | 285 049 670 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 660 | 3 581 326 | −0,05 | 78,76 | −130 750 | 282 083 142 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 336 | 3 582 986 | −0,04 | 79,13 | −105 718 | 283 521 682 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 011 | 3 584 322 | −0,06 | 78,82 | −158 517 | 282 534 182 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −494 | 3 586 333 | −0,01 | 78,21 | −38 636 | 280 487 104 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 233 | 3 586 827 | −0,20 | 78,79 | −569 888 | 282 606 099 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 594 060 | −0,01 | 78,99 | −23 697 | 283 894 799 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −69 | 3 594 360 | 0,00 | 79,90 | −5 513 | 287 189 364 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 594 429 | −0,01 | 79,87 | −39 935 | 287 087 044 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 956 | 3 594 929 | −0,22 | 78,04 | −620 886 | 280 548 259 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 277 | 3 602 885 | −0,06 | 78,67 | −179 132 | 283 438 963 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 605 162 | −0,02 | 78,72 | −55 108 | 283 816 378 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 900 | 3 605 862 | −0,11 | 79,17 | −308 763 | 285 476 095 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 337 | 3 609 762 | −0,09 | 78,48 | −261 888 | 283 294 122 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −805 | 3 613 099 | −0,02 | 78,78 | −63 414 | 284 621 874 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 200 | 3 613 904 | −0,03 | 79,63 | −95 556 | 287 775 176 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −800 | 3 615 104 | −0,02 | 79,42 | −63 536 | 287 111 560 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 465 | 3 615 904 | −0,04 | 78,41 | −114 871 | 283 523 033 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −900 | 3 617 369 | −0,02 | 79,22 | −71 298 | 286 567 972 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 974 | 3 618 269 | −0,30 | 78,16 | −857 728 | 282 803 905 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −212 | 3 629 243 | −0,01 | 79,52 | −16 858 | 288 597 403 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 629 455 | −0,01 | 79,00 | −31 600 | 286 726 945 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 3 629 855 | −0,04 | 79,74 | −111 636 | 289 444 638 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −450 | 3 631 255 | −0,01 | 78,37 | −35 266 | 284 581 454 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 915 | 3 631 705 | −0,08 | 79,48 | −231 684 | 288 647 913 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 998 | 3 634 620 | −0,08 | 79,04 | −236 962 | 287 280 365 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 185 | 3 637 618 | −0,11 | 78,83 | −329 904 | 286 753 427 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 641 803 | −0,01 | 79,24 | −15 848 | 288 576 470 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 500 | 3 642 003 | −0,04 | 78,54 | −117 810 | 286 042 916 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 262 | 3 643 503 | −0,06 | 78,57 | −177 725 | 286 270 031 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −123 | 3 645 765 | 0,00 | 79,48 | −9 775 | 289 747 173 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 100 | 3 645 888 | −0,03 | 78,45 | −86 295 | 286 019 914 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 691 | 3 646 988 | −0,05 | 78,75 | −133 166 | 287 200 305 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 237 | 3 648 679 | −0,06 | 78,81 | −176 298 | 287 552 392 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 095 | 3 650 916 | −0,38 | 78,85 | −1 111 391 | 287 874 727 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 739 | 3 665 011 | −0,07 | 78,70 | −215 559 | 288 436 366 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 3 667 750 | −0,02 | 78,22 | −46 932 | 286 891 405 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 261 | 3 668 350 | −0,06 | 78,27 | −176 968 | 287 121 754 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 670 611 | −0,01 | 79,20 | −15 840 | 290 703 215 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 171 | 3 670 811 | −0,03 | 78,80 | −92 281 | 289 278 261 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 206 | 3 671 982 | −0,06 | 78,20 | −172 509 | 287 148 992 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −800 | 3 674 188 | −0,02 | 79,79 | −63 832 | 293 163 461 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 709 | 3 674 988 | −0,10 | 78,03 | −289 413 | 286 759 314 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 675 | 3 678 697 | −0,15 | 78,18 | −443 672 | 287 600 531 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 754 | 3 684 372 | −0,10 | 78,10 | −293 187 | 287 749 453 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −294 700 | 0 | −100,00 | ||||
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −295 000 | 0 | −100,00 | ||||
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 700 | 3 688 126 | −0,13 | 78,19 | −367 493 | 288 374 572 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 692 826 | 0,00 | 78,87 | −7 887 | 291 243 955 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 692 926 | 0,00 | 79,72 | −7 972 | 294 400 061 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 693 026 | 0,00 | 78,78 | −7 878 | 290 927 356 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 008 | 3 693 126 | −0,08 | 79,20 | −238 234 | 292 495 579 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 092 | 3 696 134 | −0,19 | 78,90 | −559 559 | 291 624 973 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 649 | 3 703 226 | −0,07 | 78,90 | −208 993 | 292 166 015 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −812 | 3 705 875 | −0,02 | 79,11 | −64 237 | 293 171 771 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 960 | 3 706 687 | −0,05 | 78,64 | −154 134 | 291 493 866 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 708 647 | −0,01 | 78,97 | −23 691 | 292 871 854 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −123 | 3 708 947 | 0,00 | 78,40 | −9 644 | 290 799 990 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 709 070 | 0,00 | 78,60 | −7 860 | 291 532 902 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 908 | 3 709 170 | −0,29 | 78,06 | −851 424 | 289 519 264 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 725 | 3 720 078 | −0,05 | 78,13 | −134 774 | 290 649 694 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 680 | 3 721 803 | −0,10 | 79,51 | −292 597 | 295 920 557 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 800 | 3 725 483 | −0,21 | 78,71 | −613 938 | 293 232 767 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 600 | 3 733 283 | −0,12 | 79,05 | −363 630 | 295 116 021 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 442 | 3 737 883 | −0,15 | 79,01 | −429 972 | 295 330 136 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −723 | 3 743 325 | −0,02 | 79,12 | −57 204 | 296 171 874 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 744 048 | −0,01 | 78,07 | −31 228 | 292 301 571 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 744 448 | 0,00 | 79,92 | −7 992 | 299 275 006 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 130 | 3 744 548 | −0,03 | 79,69 | −90 050 | 298 403 030 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 745 678 | −0,01 | 79,20 | −23 758 | 296 638 969 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −250 | 3 745 978 | −0,01 | 79,53 | −19 882 | 297 917 630 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 683 | 3 746 228 | −0,04 | 78,96 | −132 890 | 295 802 163 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 747 911 | 0,00 | 79,21 | −7 921 | 296 872 030 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 383 | 3 748 011 | −0,33 | 78,15 | −967 731 | 292 907 060 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 471 | 3 760 394 | −0,09 | 78,18 | −271 380 | 294 006 405 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 294 700 | 3 763 865 | 8,49 | 22,39 | 6 598 893 | 84 280 089 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 295 000 | 3 469 165 | 9,29 | 26,19 | 7 725 430 | 90 850 146 | |
2019-03-06 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −427 | 8 462 | −4,80 | 137,73 | −58 811 | 1 165 471 | |
2019-03-06 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 084 | 8 865 | 13,93 | ||||
2019-03-04 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −52 302 | 3 174 165 | −1,62 | 77,23 | −4 039 283 | 245 140 763 | |
2019-02-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 522 272 | 522 272 | |||||
2019-02-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 99 637 | 3 226 467 | 3,19 | ||||
2019-01-31 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −725 | 7 032 | −9,35 | 95,50 | −69 238 | 671 556 | |
2019-01-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 336 | 9 193 | 3,79 | 126,31 | 42 440 | 1 161 168 | |
2019-01-03 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 986 | 14 969 | 7,05 | 177,57 | 175 001 | 2 658 063 | |
2018-12-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −6 071 | 3 126 830 | −0,19 | ||||
2018-12-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −642 | 0 | −100,00 | ||||
2018-12-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 642 | 642 | |||||
2018-12-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 284 | 3 132 901 | −0,04 | ||||
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −119 | 3 134 185 | 0,00 | 72,60 | −8 639 | 227 526 160 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 134 304 | −0,02 | 72,59 | −36 295 | 227 519 127 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 900 | 3 134 804 | −0,09 | 72,58 | −210 496 | 227 539 748 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 137 704 | −0,01 | 72,58 | −29 032 | 227 734 556 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 600 | 3 138 104 | −0,05 | 72,58 | −116 120 | 227 747 898 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 139 704 | 0,00 | 72,57 | −7 257 | 227 848 319 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 139 804 | 0,00 | 72,56 | −7 256 | 227 839 877 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 100 | 3 139 904 | −0,04 | 72,54 | −79 800 | 227 784 336 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 3 141 004 | −0,02 | 72,54 | −43 524 | 227 848 430 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 620 | 3 141 604 | −0,05 | 72,54 | −117 507 | 227 876 246 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 300 | 3 143 224 | −0,26 | 72,53 | −601 999 | 227 978 037 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −130 | 3 151 524 | 0,00 | 72,53 | −9 429 | 228 572 157 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −11 945 | 3 151 654 | −0,38 | 72,52 | −866 311 | 228 573 706 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 400 | 3 163 599 | −0,17 | 72,52 | −391 608 | 229 424 199 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −64 374 | 3 168 999 | −1,99 | 72,52 | −4 668 081 | 229 799 962 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 961 | 3 233 373 | −0,06 | 72,51 | −142 192 | 234 451 876 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 859 | 3 235 334 | −0,12 | 72,50 | −279 797 | 234 577 892 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 700 | 3 239 193 | −0,14 | 72,50 | −340 750 | 234 841 492 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 683 | 3 243 893 | −0,39 | 72,50 | −919 454 | 235 166 023 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 3 256 576 | −0,04 | 72,49 | −101 486 | 236 069 194 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 463 | 3 257 976 | −0,23 | 72,48 | −540 956 | 236 154 390 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −900 | 3 265 439 | −0,03 | 72,48 | −65 232 | 236 679 019 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −61 | 3 266 339 | 0,00 | 72,48 | −4 421 | 236 727 919 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −518 | 3 266 400 | −0,02 | 72,46 | −37 537 | 236 699 676 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −210 | 3 266 918 | −0,01 | 72,46 | −15 217 | 236 720 878 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 147 | 3 267 128 | −0,16 | 72,46 | −372 926 | 236 719 759 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 000 | 3 272 275 | −0,09 | 72,45 | −217 350 | 237 076 324 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 800 | 3 275 275 | −0,05 | 72,44 | −130 401 | 237 277 297 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −856 | 3 277 075 | −0,03 | 72,44 | −62 009 | 237 391 313 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 401 | 3 277 931 | −0,10 | 72,44 | −246 351 | 237 436 932 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 600 | 3 281 332 | −0,20 | 72,43 | −478 038 | 237 666 877 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 716 | 3 287 932 | −0,17 | 72,42 | −413 981 | 238 128 475 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 674 | 3 293 648 | −0,17 | 72,42 | −410 911 | 238 525 988 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 177 | 3 299 322 | −0,31 | 72,42 | −736 967 | 238 920 403 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 345 | 3 309 499 | −0,22 | 72,41 | −531 851 | 239 640 823 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −325 000 | 0 | −100,00 | ||||
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 538 | 3 316 844 | −0,38 | 72,40 | −907 814 | 240 156 090 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 564 | 3 329 382 | −0,41 | 72,40 | −982 034 | 241 047 257 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 022 | 3 342 946 | −0,30 | 72,40 | −725 543 | 242 012 576 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 100 | 3 352 968 | −0,09 | 72,39 | −224 409 | 242 721 354 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 462 | 3 356 068 | −0,16 | 72,38 | −395 367 | 242 928 982 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 200 | 3 361 530 | −0,15 | 72,38 | −376 376 | 243 307 541 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 761 | 3 366 730 | −0,05 | 72,38 | −127 452 | 243 667 084 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 916 | 3 368 491 | −0,06 | 72,37 | −138 661 | 243 777 694 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 008 | 3 370 407 | −0,09 | 72,36 | −217 674 | 243 899 503 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 800 | 3 373 415 | −0,11 | 72,36 | −274 968 | 244 100 309 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 181 | 3 377 215 | −0,21 | 72,36 | −519 581 | 244 358 391 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 250 | 3 384 396 | −0,13 | 72,35 | −307 488 | 244 861 051 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 290 | 3 388 646 | −0,42 | 72,34 | −1 033 810 | 245 151 595 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 825 | 3 402 936 | −0,20 | 72,34 | −493 720 | 246 168 390 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 460 | 3 409 761 | −0,10 | 72,34 | −250 279 | 246 645 062 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 595 | 3 413 221 | −0,05 | 72,33 | −115 366 | 246 878 275 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 945 | 3 414 816 | −0,20 | 72,32 | −502 297 | 246 976 567 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 100 | 3 421 761 | −0,15 | 72,32 | −368 832 | 247 461 756 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 300 | 3 426 861 | −0,07 | 72,32 | −166 324 | 247 813 453 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 385 | 3 429 161 | −0,13 | 72,31 | −317 079 | 247 962 632 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 757 | 3 433 546 | −0,31 | 72,30 | −777 785 | 248 262 544 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 381 | 3 444 303 | −0,04 | 72,30 | −99 846 | 249 023 107 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 327 | 3 445 684 | −0,04 | 72,30 | −95 935 | 249 105 725 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 102 | 3 447 011 | −0,06 | 72,29 | −151 954 | 249 184 425 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −231 | 3 449 113 | −0,01 | 72,29 | −16 698 | 249 327 756 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 870 | 3 449 344 | −0,14 | 72,28 | −352 028 | 249 335 831 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 771 | 3 454 214 | −0,08 | 72,28 | −200 288 | 249 670 588 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 3 456 985 | −0,04 | 72,28 | −101 185 | 249 853 591 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −800 | 3 458 385 | −0,02 | 72,27 | −57 816 | 249 937 484 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 325 000 | 3 459 185 | 10,37 | 26,02 | 8 454 875 | 89 990 698 | |
2018-10-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 280 | 8 795 | 3,29 | 151,74 | 42 487 | 1 334 553 | |
2018-07-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 311 | 8 461 | 3,82 | 136,72 | 42 520 | 1 156 788 | |
2018-06-07 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −23 923 | 3 134 185 | −0,76 | ||||
2018-04-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 289 | 8 112 | 3,69 | 147,17 | 42 532 | 1 193 843 | |
2018-03-07 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −549 | 7 757 | −6,61 | 153,33 | −84 178 | 1 189 381 | |
2018-03-07 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 993 | 8 306 | 13,58 | ||||
2018-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −53 462 | 3 158 108 | −1,66 | 60,55 | −3 237 124 | 191 223 439 | |
2018-02-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 688 073 | 688 073 | |||||
2018-02-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 125 125 | 3 211 570 | 4,05 | ||||
2018-01-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −440 | 3 086 445 | −0,01 | ||||
2018-01-05 |
|
4/A | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −22 890 | 3 123 692 | −0,73 | ||||
2018-01-03 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 988 | 13 637 | 7,81 | 172,12 | 169 999 | 2 347 278 | |
2018-01-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 269 | 7 784 | 3,58 | 158,00 | 42 502 | 1 229 872 | |
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −455 | 3 086 430 | −0,01 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −36 352 | 3 086 885 | −1,16 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −23 345 | 3 123 237 | −0,74 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 240 | 9 992 | 2,46 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 240 | 136 692 | 0,18 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 240 | 9 992 | 2,46 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 240 | 136 692 | 0,18 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −720 | 0 | −100,00 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 720 | 720 | |||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 440 | 3 146 582 | −0,05 | ||||
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 3 279 290 | −0,09 | 54,59 | −152 852 | 179 016 441 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −505 | 3 282 090 | −0,02 | 54,58 | −27 565 | 179 152 883 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 101 | 3 282 595 | −0,06 | 54,58 | −114 673 | 179 164 035 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −692 | 3 284 696 | −0,02 | 54,58 | −37 766 | 179 262 284 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 001 | 3 285 388 | −0,18 | 54,57 | −327 475 | 179 283 623 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 291 389 | −0,01 | 54,57 | −10 914 | 179 602 869 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 902 | 3 291 589 | −0,06 | 54,56 | −103 783 | 179 605 554 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 345 | 3 293 491 | −0,16 | 54,56 | −291 623 | 179 692 869 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 660 | 3 298 836 | −0,05 | 54,56 | −90 561 | 179 967 998 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 512 | 3 300 496 | −0,05 | 54,55 | −82 480 | 180 042 057 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 302 008 | −0,01 | 54,54 | −21 818 | 180 108 026 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 200 | 3 302 408 | −0,04 | 54,54 | −65 448 | 180 113 332 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −800 | 3 303 608 | −0,02 | 54,54 | −43 628 | 180 162 262 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 300 | 3 304 408 | −0,22 | 54,53 | −398 069 | 180 189 368 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 799 | 3 311 708 | −0,05 | 54,52 | −98 090 | 180 570 879 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 200 | 3 313 507 | −0,10 | 54,52 | −174 464 | 180 652 402 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 316 707 | 0,00 | 54,52 | −5 452 | 180 818 574 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −607 | 3 316 807 | −0,02 | 54,52 | −33 091 | 180 815 734 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 600 | 3 317 414 | −0,20 | 54,51 | −359 766 | 180 832 237 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 882 | 3 324 014 | −0,06 | 54,50 | −102 578 | 181 175 383 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 892 | 3 325 896 | −0,33 | 54,50 | −593 614 | 181 261 332 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 336 788 | 0,00 | 54,50 | −5 450 | 181 846 604 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 289 | 3 336 888 | −0,19 | 54,50 | −342 719 | 181 843 712 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 800 | 3 343 177 | −0,32 | 54,49 | −588 492 | 182 169 715 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 184 | 3 353 977 | −0,15 | 54,48 | −282 450 | 182 741 437 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 711 | 3 359 161 | −0,38 | 54,48 | −692 495 | 183 007 091 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 500 | 3 371 872 | −0,07 | 54,48 | −136 188 | 183 682 727 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 436 | 3 374 372 | −0,22 | 54,47 | −405 039 | 183 802 043 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 359 | 3 381 808 | −0,04 | 54,46 | −74 018 | 184 190 173 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −17 860 | 3 383 167 | −0,53 | 54,46 | −972 656 | 184 247 275 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −530 000 | 0 | −100,00 | ||||
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 377 | 3 401 027 | −0,07 | 54,46 | −129 440 | 185 202 925 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 800 | 3 403 404 | −0,40 | 54,45 | −751 410 | 185 315 348 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 501 | 3 417 204 | −0,10 | 54,44 | −190 612 | 186 049 672 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −9 150 | 3 420 705 | −0,27 | 54,44 | −498 126 | 186 223 180 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 833 | 3 429 855 | −0,31 | 54,44 | −589 694 | 186 704 157 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −19 665 | 3 440 688 | −0,57 | 54,43 | −1 070 366 | 187 276 648 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −21 402 | 3 460 353 | −0,61 | 54,42 | −1 164 804 | 188 329 712 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −39 699 | 3 481 755 | −1,13 | 54,42 | −2 160 420 | 189 477 107 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 521 454 | 0,00 | 54,42 | −5 442 | 191 628 723 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 167 | 3 521 554 | −0,23 | 54,42 | −444 407 | 191 625 361 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −24 651 | 3 529 721 | −0,69 | 54,41 | −1 341 261 | 192 052 120 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 554 372 | 0,00 | 54,41 | −5 441 | 193 384 495 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 181 | 3 554 472 | −0,40 | 54,40 | −771 517 | 193 381 049 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −19 900 | 3 568 653 | −0,55 | 54,40 | −1 082 560 | 194 134 723 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 588 553 | 0,00 | 54,40 | −5 440 | 195 208 312 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 435 | 3 588 653 | −0,15 | 54,40 | −295 637 | 195 204 780 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −27 636 | 3 594 088 | −0,76 | 54,39 | −1 503 122 | 195 482 446 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 502 | 3 621 724 | −0,23 | 54,38 | −462 381 | 196 967 460 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −16 446 | 3 630 226 | −0,45 | 54,38 | −894 333 | 197 411 690 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 199 | 3 646 672 | −0,14 | 54,38 | −282 696 | 198 287 790 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 035 | 3 651 871 | −0,22 | 54,37 | −436 863 | 198 552 226 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 407 | 3 659 906 | −0,07 | 54,36 | −130 857 | 198 970 790 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 450 | 3 662 313 | −0,20 | 54,36 | −404 982 | 199 083 335 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 650 | 3 669 763 | −0,07 | 54,36 | −144 041 | 199 469 968 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −800 | 3 672 413 | −0,02 | 54,35 | −43 480 | 199 595 647 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 673 213 | −0,01 | 54,34 | −16 304 | 199 620 760 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 000 | 3 673 513 | −0,03 | 54,34 | −54 340 | 199 618 696 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 3 674 513 | −0,08 | 54,33 | −152 124 | 199 636 291 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 3 677 313 | −0,02 | 54,32 | −32 595 | 199 770 029 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 530 000 | 3 677 913 | 16,84 | 26,70 | 14 149 569 | 98 190 347 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −204 | 3 148 022 | −0,01 | 55,02 | −11 224 | 173 204 170 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 148 117 | 0,00 | 55,00 | −5 500 | 173 146 435 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 3 148 217 | −0,02 | 54,99 | −32 994 | 173 120 453 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −615 | 3 148 817 | −0,02 | 54,98 | −33 813 | 173 121 959 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 149 432 | −0,01 | 54,98 | −10 995 | 173 140 024 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 199 | 3 149 632 | −0,04 | 54,97 | −65 909 | 173 135 271 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 150 831 | 0,00 | 54,96 | −5 496 | 173 185 426 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 150 931 | −0,01 | 54,96 | −21 984 | 173 175 168 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 | 3 151 331 | 0,00 | 54,96 | −165 | 173 181 395 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −428 | 3 151 334 | −0,01 | 54,95 | −23 519 | 173 165 803 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 151 762 | −0,01 | 54,94 | −10 989 | 173 173 563 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 200 | 3 151 962 | −0,04 | 54,94 | −65 928 | 173 168 792 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 600 | 3 153 162 | −0,05 | 54,93 | −87 888 | 173 203 189 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −392 | 3 154 762 | −0,01 | 54,92 | −21 531 | 173 275 303 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 300 | 3 155 154 | −0,10 | 54,92 | −181 236 | 173 281 058 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −103 | 3 158 454 | 0,00 | 54,92 | −5 656 | 173 446 501 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 207 | 3 158 557 | −0,07 | 54,91 | −121 186 | 173 436 365 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −797 | 3 160 764 | −0,03 | 54,90 | −43 759 | 173 541 747 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 618 | 3 161 561 | −0,05 | 54,90 | −88 828 | 173 569 699 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −499 | 3 163 179 | −0,02 | 54,90 | −27 393 | 173 642 711 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 500 | 3 163 678 | −0,05 | 54,89 | −82 335 | 173 654 285 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 103 | 3 165 178 | −0,10 | 54,88 | −170 293 | 173 704 969 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 168 281 | 0,00 | 54,88 | −5 488 | 173 859 420 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 897 | 3 168 381 | −0,12 | 54,87 | −213 828 | 173 849 065 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −197 | 3 172 278 | −0,01 | 54,86 | −10 808 | 174 047 032 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 500 | 3 172 475 | −0,08 | 54,86 | −137 150 | 174 041 978 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −144 | 3 174 975 | 0,00 | 54,86 | −7 899 | 174 163 254 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 975 | 3 175 119 | −0,22 | 54,85 | −382 579 | 174 155 277 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 359 | 3 182 094 | −0,07 | 54,84 | −129 379 | 174 521 945 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 297 | 3 184 453 | −0,13 | 54,84 | −235 647 | 174 635 403 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 000 | 3 188 750 | −0,03 | 54,84 | −54 835 | 174 855 106 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 403 | 3 189 750 | −0,08 | 54,83 | −131 756 | 174 893 992 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 192 153 | −0,01 | 54,82 | −10 965 | 175 009 788 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 500 | 3 192 353 | −0,14 | 54,82 | −246 690 | 175 004 791 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 602 | 3 196 853 | −0,05 | 54,82 | −87 814 | 175 235 497 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 200 | 3 198 455 | −0,19 | 54,81 | −339 822 | 175 307 319 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −398 | 3 204 655 | −0,01 | 54,80 | −21 812 | 175 631 117 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 600 | 3 205 053 | −0,17 | 54,80 | −306 880 | 175 636 904 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 200 | 3 210 653 | −0,04 | 54,80 | −65 754 | 175 927 731 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 300 | 3 211 853 | −0,07 | 54,79 | −126 017 | 175 977 426 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 3 214 153 | −0,04 | 54,78 | −76 699 | 176 087 372 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 898 | 3 215 553 | −0,12 | 54,78 | −213 532 | 176 147 993 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 097 | 3 219 451 | −0,03 | 54,78 | −60 088 | 176 345 429 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 439 | 3 220 548 | −0,14 | 54,77 | −243 124 | 176 389 414 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −398 | 3 224 987 | −0,01 | 54,76 | −21 796 | 176 616 413 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 702 | 3 225 385 | −0,15 | 54,76 | −257 482 | 176 622 083 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 156 | 3 230 087 | −0,04 | 54,76 | −63 297 | 176 863 414 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 600 | 3 231 243 | −0,08 | 54,75 | −142 350 | 176 910 554 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −606 | 3 233 843 | −0,02 | 54,74 | −33 175 | 177 036 735 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 500 | 3 234 449 | −0,14 | 54,74 | −246 330 | 177 053 738 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 534 | 3 238 949 | −0,05 | 54,74 | −83 963 | 177 283 874 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 760 | 3 240 483 | −0,05 | 54,73 | −96 325 | 177 351 635 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −866 | 3 242 243 | −0,03 | 54,72 | −47 392 | 177 431 748 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 500 | 3 243 109 | −0,17 | 54,72 | −300 960 | 177 462 924 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 000 | 3 248 609 | −0,09 | 54,72 | −164 145 | 177 747 641 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 900 | 3 251 609 | −0,18 | 54,71 | −322 789 | 177 895 528 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 000 | 3 257 509 | −0,03 | 54,70 | −54 705 | 178 202 030 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 706 | 3 258 509 | −0,08 | 54,70 | −148 018 | 178 240 442 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −394 | 3 261 215 | −0,01 | 54,70 | −21 550 | 178 372 154 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 3 261 609 | −0,09 | 54,69 | −153 132 | 178 377 396 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 3 264 409 | −0,04 | 54,68 | −71 090 | 178 514 206 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 700 | 3 265 709 | −0,05 | 54,68 | −92 956 | 178 568 968 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 267 409 | −0,02 | 54,68 | −38 272 | 178 645 587 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 268 109 | −0,02 | 54,67 | −38 269 | 178 667 519 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 268 809 | −0,01 | 54,66 | −10 933 | 178 689 444 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 700 | 3 269 009 | −0,05 | 54,66 | −92 922 | 178 684 032 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 270 709 | −0,02 | 54,66 | −27 328 | 178 760 600 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 271 209 | −0,01 | 54,64 | −21 856 | 178 738 860 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 271 609 | −0,02 | 54,64 | −38 244 | 178 744 358 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 3 272 309 | −0,04 | 54,63 | −71 019 | 178 766 241 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −900 | 3 273 609 | −0,03 | 54,62 | −49 158 | 178 804 524 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 274 509 | 0,00 | 54,62 | −5 462 | 178 837 309 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 274 609 | −0,01 | 54,61 | −10 922 | 178 826 397 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −295 | 3 274 809 | −0,01 | 54,60 | −16 108 | 178 820 945 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 586 | 3 275 104 | −0,11 | 54,60 | −195 796 | 178 820 678 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 3 278 690 | −0,02 | 54,60 | −32 757 | 179 000 081 | |
2017-12-05 |
|
4/A | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 92 342 | 3 207 105 | 2,96 | ||||
2017-10-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 340 | 7 473 | 4,77 | 125,03 | 42 510 | 934 349 | |
2017-07-05 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 397 | 7 085 | 5,94 | 106,94 | 42 455 | 757 670 | |
2017-04-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 459 | 6 637 | 7,43 | 92,63 | 42 517 | 614 785 | |
2017-03-08 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 307 | 7 313 | 21,76 | ||||
2017-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −59 192 | 3 143 077 | −1,85 | 45,46 | −2 690 868 | 142 884 280 | |
2017-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 638 629 | 638 629 | |||||
2017-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 92 342 | 3 202 269 | 2,97 | ||||
2017-01-04 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 238 | 12 335 | 11,16 | 121,72 | 150 725 | 1 501 398 | |
2017-01-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 458 | 6 131 | 8,07 | 92,79 | 42 498 | 568 895 | |
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 340 | 3 178 381 | 0,01 | ||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 340 | 129 888 | 0,26 | ||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 340 | 9 512 | 3,71 | ||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 340 | 9 512 | 3,71 | ||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 020 | 0 | −100,00 | ||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 1 020 | 1 020 | |||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −2 040 | 3 109 927 | −0,07 | ||||
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 200 | 3 111 967 | 0,07 | 40,70 | 89 529 | 126 641 497 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 900 | 3 109 767 | 0,03 | 40,58 | 36 526 | 126 209 894 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 911 | 3 108 867 | 0,19 | 40,72 | 240 725 | 126 608 609 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 3 102 956 | 0,03 | 40,62 | 40 615 | 126 026 558 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 400 | 3 101 956 | 0,08 | 40,45 | 97 080 | 125 474 120 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 550 | 3 099 556 | 0,11 | 40,74 | 144 645 | 126 291 409 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 424 | 3 096 006 | 0,05 | 40,59 | 57 800 | 125 666 884 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 000 | 3 094 582 | 0,29 | 40,73 | 366 570 | 126 042 325 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 900 | 3 085 582 | 0,13 | 40,57 | 158 223 | 125 182 062 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 3 081 682 | 0,02 | 40,72 | 20 361 | 125 493 795 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 3 081 182 | 0,01 | 40,64 | 8 129 | 125 234 642 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 800 | 3 080 982 | 0,06 | 40,60 | 73 080 | 125 087 869 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 500 | 3 079 182 | 0,15 | 40,66 | 182 948 | 125 184 144 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 300 | 3 074 682 | 0,11 | 40,68 | 134 260 | 125 093 437 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 900 | 3 071 382 | 0,09 | 40,58 | 117 682 | 124 636 682 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 700 | 3 068 482 | 0,09 | 40,63 | 109 701 | 124 672 424 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 3 065 782 | 0,06 | 40,74 | 69 250 | 124 884 630 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 978 | 3 064 082 | 0,20 | 40,76 | 243 633 | 124 876 662 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 3 058 104 | 0,03 | 40,54 | 40 540 | 123 975 536 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 3 057 104 | 0,03 | 40,70 | 40 705 | 124 439 418 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 700 | 3 056 104 | 0,02 | 40,54 | 28 382 | 123 909 737 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 3 055 404 | 0,00 | 40,71 | 4 071 | 124 393 135 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 600 | 3 055 304 | 0,05 | 40,62 | 64 992 | 124 106 448 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 700 | 3 053 704 | 0,02 | 40,49 | 28 343 | 123 644 475 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 100 | 3 053 004 | 0,04 | 40,67 | 44 737 | 124 165 673 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 402 | 3 051 904 | 0,08 | 40,44 | 97 137 | 123 418 998 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 100 | 3 049 502 | 0,07 | 40,48 | 85 008 | 123 443 841 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 100 | 3 047 402 | 0,20 | 40,65 | 247 965 | 123 876 891 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 3 041 302 | 0,01 | 40,73 | 8 146 | 123 879 834 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 900 | 3 041 102 | 0,06 | 40,60 | 77 150 | 123 483 947 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 3 039 202 | 0,03 | 40,47 | 40 470 | 122 996 505 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 400 | 3 038 202 | 0,05 | 40,77 | 57 078 | 123 867 496 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 3 036 802 | 0,02 | 40,51 | 20 255 | 123 020 849 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 3 036 302 | 0,00 | 40,74 | 4 074 | 123 706 534 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 389 | 3 036 202 | 0,21 | 40,72 | 260 160 | 123 634 145 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 3 029 813 | 0,01 | 40,64 | 8 128 | 123 139 175 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 3 029 613 | 0,02 | 40,44 | 24 267 | 122 532 698 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 225 | 3 029 013 | 0,11 | 40,74 | 131 386 | 123 401 990 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 3 025 788 | 0,02 | 40,44 | 24 261 | 122 347 738 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 800 | 3 025 188 | 0,03 | 40,66 | 32 528 | 123 004 144 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 600 | 3 024 388 | 0,09 | 40,72 | 105 859 | 123 137 957 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 3 021 788 | 0,00 | 40,80 | 4 080 | 123 273 841 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 200 | 3 021 688 | 0,04 | 40,75 | 48 903 | 123 141 340 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 400 | 3 020 488 | 0,01 | 40,76 | 16 305 | 123 122 642 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 800 | 3 020 088 | 0,03 | 40,76 | 32 612 | 123 113 887 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 300 | 3 019 288 | 0,04 | 40,56 | 52 722 | 122 447 225 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 440 | 3 017 988 | 0,05 | 40,55 | 58 392 | 122 379 413 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 3 016 548 | 0,03 | 40,46 | 40 455 | 122 034 449 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 3 015 548 | 0,01 | 40,50 | 12 148 | 122 114 616 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 900 | 3 015 248 | 0,13 | 40,76 | 158 964 | 122 901 508 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 605 | 3 011 348 | 0,05 | 40,64 | 65 227 | 122 381 183 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 3 009 743 | 0,02 | 40,53 | 20 265 | 121 984 884 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 300 | 3 009 243 | 0,14 | 40,71 | 175 053 | 122 506 283 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 400 | 3 004 943 | 0,08 | 40,61 | 97 464 | 122 030 735 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 300 | 3 002 543 | 0,11 | 40,56 | 133 848 | 121 783 144 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 999 243 | 0,02 | 40,79 | 20 395 | 122 339 122 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 100 | 2 998 743 | 0,07 | 40,60 | 85 250 | 121 733 972 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 996 643 | 0,01 | 40,68 | 8 135 | 121 888 454 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 800 | 2 996 443 | 0,09 | 40,68 | 113 904 | 121 895 301 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 776 | 2 993 643 | 0,16 | 40,75 | 194 622 | 121 990 952 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 2 988 867 | 0,06 | 40,78 | 69 326 | 121 885 996 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 13 700 | 2 987 167 | 0,46 | 40,46 | 554 302 | 120 860 777 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 000 | 2 973 467 | 0,10 | 40,46 | 121 395 | 120 321 342 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 800 | 2 970 467 | 0,03 | 40,58 | 32 460 | 120 526 699 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 2 969 667 | 0,03 | 40,52 | 40 520 | 120 330 907 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 200 | 2 968 667 | 0,07 | 40,70 | 89 540 | 120 824 747 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 400 | 2 966 467 | 0,08 | 40,69 | 97 656 | 120 705 542 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 100 | 2 964 067 | 0,07 | 40,80 | 85 680 | 120 933 934 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 000 | 2 961 967 | 0,07 | 40,42 | 80 840 | 119 722 706 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 2 959 967 | 0,03 | 40,40 | 40 395 | 119 567 867 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 16 690 | 2 958 967 | 0,57 | 40,45 | 675 110 | 119 690 215 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 600 | 2 942 277 | 0,05 | 40,59 | 64 944 | 119 427 023 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 622 | 2 940 677 | 0,06 | 40,38 | 65 488 | 118 729 834 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 025 | 2 939 055 | 0,14 | 40,39 | 162 570 | 118 708 431 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 935 030 | 0,02 | 40,42 | 24 249 | 118 619 237 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 800 | 2 934 430 | 0,13 | 40,57 | 154 166 | 119 049 825 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 500 | 2 930 630 | 0,05 | 40,40 | 60 608 | 118 412 105 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 900 | 2 929 130 | 0,06 | 40,60 | 77 140 | 118 922 678 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 700 | 2 927 230 | 0,13 | 40,58 | 150 146 | 118 786 993 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 923 530 | 0,02 | 40,63 | 20 315 | 118 783 024 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 923 030 | 0,01 | 40,46 | 8 092 | 118 273 101 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 200 | 2 922 830 | 0,08 | 40,52 | 89 133 | 118 418 457 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 265 | 2 920 630 | 0,18 | 40,38 | 212 601 | 117 935 039 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 400 | 2 915 365 | 0,05 | 40,54 | 56 756 | 118 188 897 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 678 | 2 913 965 | 0,06 | 40,36 | 67 732 | 117 622 197 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 912 287 | 0,02 | 40,50 | 20 252 | 117 962 185 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 17 900 | 2 911 787 | 0,62 | 40,40 | 723 160 | 117 636 195 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 893 887 | 0,01 | 40,35 | 8 070 | 116 768 340 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 893 687 | 0,00 | 40,44 | 4 044 | 117 027 936 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 293 | 2 893 587 | 0,04 | 40,49 | 52 354 | 117 161 338 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 892 294 | 0,00 | 40,67 | 4 067 | 117 629 597 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 37 120 | 2 892 194 | 1,30 | 40,44 | 1 501 133 | 116 960 325 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 479 | 2 855 074 | 0,19 | 40,48 | 221 790 | 115 573 396 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 849 595 | 0,02 | 40,44 | 20 220 | 115 240 471 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 849 095 | 0,01 | 40,65 | 12 195 | 115 815 712 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 848 795 | 0,02 | 40,42 | 20 212 | 115 162 538 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 800 | 2 848 295 | 0,10 | 40,47 | 113 316 | 115 270 499 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 100 | 2 845 495 | 0,25 | 40,51 | 287 621 | 115 271 002 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 700 | 2 838 395 | 0,20 | 40,37 | 230 109 | 114 586 006 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 320 | 2 832 695 | 0,19 | 40,44 | 215 167 | 114 568 349 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 500 | 2 827 375 | 0,09 | 40,44 | 101 088 | 114 324 908 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 211 | 2 824 875 | 0,04 | 40,48 | 49 027 | 114 365 064 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 400 | 2 823 664 | 0,01 | 40,52 | 16 210 | 114 428 984 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 200 | 2 823 264 | 0,08 | 40,55 | 89 210 | 114 483 355 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 600 | 2 821 064 | 0,13 | 40,46 | 145 638 | 114 126 144 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 200 | 2 817 464 | 0,18 | 40,50 | 210 600 | 114 107 292 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 996 | 2 812 264 | 0,04 | 40,50 | 40 333 | 113 882 631 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 811 268 | 0,00 | 40,64 | 4 064 | 114 249 932 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 2 811 168 | 0,06 | 40,53 | 68 901 | 113 936 639 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 100 | 2 809 468 | 0,04 | 40,61 | 44 671 | 114 092 495 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 210 | 2 808 368 | 0,19 | 40,56 | 211 318 | 113 907 406 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 803 158 | 0,02 | 40,68 | 24 408 | 114 032 467 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 8 649 | 2 802 558 | 0,31 | 40,36 | 349 074 | 113 111 241 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 793 909 | 0,01 | 40,41 | 8 082 | 112 908 847 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 121 | 2 793 709 | 0,18 | 40,43 | 207 042 | 112 949 655 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 900 | 2 788 588 | 0,36 | 40,46 | 400 554 | 112 826 270 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 021 | 2 778 688 | 0,07 | 40,48 | 81 800 | 112 467 397 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 400 | 2 776 667 | 0,05 | 40,46 | 56 651 | 112 357 830 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 200 | 2 775 267 | 0,04 | 40,52 | 48 624 | 112 453 819 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 774 067 | 0,00 | 40,52 | 4 052 | 112 412 130 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 773 967 | 0,02 | 40,38 | 24 231 | 112 026 657 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 11 100 | 2 773 367 | 0,40 | 40,41 | 448 551 | 112 071 760 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 762 267 | 0,01 | 40,47 | 12 142 | 111 795 851 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 761 967 | 0,02 | 40,75 | 24 450 | 112 550 155 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 761 367 | 0,00 | 40,74 | 4 074 | 112 511 898 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 400 | 2 761 267 | 0,01 | 40,74 | 16 296 | 112 494 018 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 760 867 | 0,01 | 40,73 | 12 219 | 112 450 113 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 760 567 | 0,00 | 40,72 | 4 072 | 112 424 091 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 2 760 467 | 0,04 | 40,72 | 40 720 | 112 406 216 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 300 | 2 759 467 | 0,05 | 40,72 | 52 930 | 112 351 699 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 300 | 2 758 167 | 0,05 | 40,71 | 52 923 | 112 284 979 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 756 867 | 0,01 | 40,70 | 12 212 | 112 218 271 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 200 | 2 756 567 | 0,04 | 40,70 | 48 840 | 112 192 277 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 200 | 2 755 367 | 0,04 | 40,70 | 48 834 | 112 129 660 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 600 | 2 754 167 | 0,06 | 40,69 | 65 104 | 112 067 055 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 150 | 2 752 567 | 0,04 | 40,68 | 46 788 | 111 988 188 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 2 751 417 | 0,06 | 40,68 | 69 156 | 111 927 644 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 800 | 2 749 717 | 0,03 | 40,68 | 32 540 | 111 844 739 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 700 | 2 748 917 | 0,10 | 40,67 | 109 809 | 111 798 454 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 746 217 | 0,02 | 40,66 | 24 399 | 111 674 914 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 2 745 617 | 0,06 | 40,66 | 69 122 | 111 636 787 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 743 917 | 0,02 | 40,66 | 24 393 | 111 553 946 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 300 | 2 743 317 | 0,05 | 40,65 | 52 845 | 111 515 836 | |
2016-10-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 481 | 5 623 | 9,35 | 88,40 | 42 520 | 497 073 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 742 017 | 0,01 | 43,37 | 8 674 | 118 921 277 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 300 | 2 741 817 | 0,19 | 43,30 | 229 490 | 118 720 676 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 736 517 | 0,02 | 43,38 | 26 031 | 118 723 790 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 735 917 | 0,00 | 43,33 | 4 333 | 118 554 123 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 000 | 2 735 817 | 0,11 | 43,34 | 130 035 | 118 583 988 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 000 | 2 732 817 | 0,07 | 43,35 | 86 700 | 118 467 617 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 800 | 2 730 817 | 0,18 | 43,36 | 208 152 | 118 421 879 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 726 017 | 0,02 | 43,38 | 21 690 | 118 254 617 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 900 | 2 725 517 | 0,03 | 43,32 | 38 984 | 118 055 769 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 724 617 | 0,01 | 43,28 | 12 984 | 117 921 424 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 233 | 2 724 317 | 0,01 | 43,30 | 10 089 | 117 969 737 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 067 | 2 724 084 | 0,22 | 43,31 | 262 762 | 117 980 078 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 700 | 2 718 017 | 0,17 | 43,34 | 203 698 | 117 798 857 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 100 | 2 713 317 | 0,26 | 43,33 | 307 643 | 117 568 026 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 600 | 2 706 217 | 0,06 | 43,28 | 69 256 | 117 138 603 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 500 | 2 704 617 | 0,13 | 43,30 | 151 532 | 117 096 393 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 400 | 2 701 117 | 0,13 | 43,36 | 147 407 | 117 106 928 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 900 | 2 697 717 | 0,11 | 43,36 | 125 744 | 116 973 009 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 141 | 2 694 817 | 0,04 | 43,38 | 49 491 | 116 887 687 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 693 676 | 0,00 | 43,34 | 4 334 | 116 750 652 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 200 | 2 693 576 | 0,27 | 43,32 | 311 940 | 116 699 180 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 780 | 2 686 376 | 0,10 | 43,34 | 120 471 | 116 414 104 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 12 879 | 2 683 596 | 0,48 | 43,30 | 557 725 | 116 213 125 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 800 | 2 670 717 | 0,29 | 43,32 | 337 896 | 115 695 460 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 662 917 | 0,02 | 43,39 | 21 695 | 115 543 969 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 900 | 2 662 417 | 0,07 | 43,29 | 82 251 | 115 256 032 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 660 517 | 0,02 | 43,26 | 21 630 | 115 096 626 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 600 | 2 660 017 | 0,36 | 43,12 | 413 952 | 114 699 933 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 12 641 | 2 650 417 | 0,48 | 43,13 | 545 206 | 114 312 485 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 637 776 | 0,01 | 43,26 | 8 652 | 114 116 784 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 637 776 | 0,01 | 43,26 | 8 652 | 114 116 784 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 2 637 576 | 0,06 | 43,30 | 73 610 | 114 207 041 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 800 | 2 635 876 | 0,11 | 43,26 | 121 114 | 114 014 816 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 633 076 | 0,00 | 43,12 | 4 312 | 113 544 820 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 979 | 2 632 976 | 0,23 | 43,18 | 258 143 | 113 678 739 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 101 | 2 626 997 | 0,16 | 43,10 | 176 733 | 113 210 436 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 10 899 | 2 622 896 | 0,42 | 43,11 | 469 856 | 113 073 047 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 42 445 | 2 611 997 | 1,65 | 43,27 | 1 836 595 | 113 021 110 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 772 | 2 569 552 | 0,07 | 43,16 | 76 488 | 110 914 712 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 300 | 2 567 780 | 0,09 | 43,20 | 99 372 | 110 940 935 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 18 000 | 2 565 280 | 0,71 | 43,37 | 780 660 | 111 256 194 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 400 | 2 547 280 | 0,17 | 43,30 | 190 520 | 110 297 224 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 909 | 2 542 880 | 0,04 | 43,38 | 39 437 | 110 322 849 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 622 | 2 541 971 | 0,06 | 43,26 | 70 160 | 109 952 956 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 900 | 2 540 349 | 0,27 | 43,34 | 299 080 | 110 111 427 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 200 | 2 533 449 | 0,29 | 43,35 | 312 120 | 109 825 014 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 200 | 2 526 249 | 0,09 | 43,27 | 95 194 | 109 310 794 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 656 | 2 524 049 | 0,38 | 43,36 | 418 732 | 109 455 385 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 700 | 2 514 393 | 0,23 | 43,38 | 247 266 | 109 074 368 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 508 693 | 0,01 | 43,25 | 12 976 | 108 507 244 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 400 | 2 508 393 | 0,22 | 43,23 | 233 442 | 108 437 829 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 700 | 2 502 993 | 0,23 | 43,28 | 246 696 | 108 329 537 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 100 | 2 497 293 | 0,16 | 43,40 | 177 920 | 108 370 030 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 914 | 2 493 193 | 0,16 | 43,31 | 169 515 | 107 980 189 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 100 | 2 489 279 | 0,25 | 43,34 | 264 374 | 107 885 352 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 100 | 2 483 179 | 0,12 | 43,40 | 134 556 | 107 782 384 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 910 | 2 480 079 | 0,12 | 43,33 | 126 090 | 107 461 823 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 452 | 2 477 169 | 0,14 | 43,28 | 149 420 | 107 224 260 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 400 | 2 473 717 | 0,02 | 43,30 | 17 318 | 107 099 578 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 108 | 2 473 317 | 0,00 | 43,38 | 4 685 | 107 298 675 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 473 209 | 0,00 | 43,23 | 4 323 | 106 923 008 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 473 109 | 0,01 | 43,32 | 8 664 | 107 141 265 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 300 | 2 472 909 | 0,21 | 43,36 | 229 782 | 107 212 970 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 148 | 2 467 609 | 0,01 | 43,28 | 6 405 | 106 785 779 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 800 | 2 467 461 | 0,07 | 43,26 | 77 868 | 106 742 363 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 465 661 | 0,00 | 43,39 | 4 339 | 106 991 195 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 465 561 | 0,00 | 43,31 | 4 331 | 106 789 611 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 800 | 2 465 461 | 0,40 | 43,36 | 424 928 | 106 902 389 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 14 511 | 2 455 661 | 0,59 | 43,38 | 629 415 | 106 514 296 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 400 | 2 441 150 | 0,06 | 43,32 | 60 655 | 105 762 824 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 423 | 2 439 750 | 0,22 | 43,34 | 235 006 | 105 726 566 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 434 327 | 0,01 | 43,37 | 13 012 | 105 582 848 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 747 | 2 434 027 | 0,03 | 43,25 | 32 308 | 105 271 668 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 433 280 | 0,00 | 43,26 | 4 326 | 105 275 859 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 900 | 2 433 180 | 0,04 | 43,24 | 38 912 | 105 198 537 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 300 | 2 432 280 | 0,05 | 43,22 | 56 192 | 105 135 303 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 500 | 2 430 980 | 0,10 | 43,30 | 108 262 | 105 273 589 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 300 | 2 428 480 | 0,18 | 43,32 | 186 276 | 105 201 754 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 800 | 2 424 180 | 0,12 | 43,39 | 121 492 | 105 185 170 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 421 380 | 0,00 | 43,35 | 4 335 | 104 972 876 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 200 | 2 421 280 | 0,17 | 43,29 | 181 818 | 104 817 211 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 600 | 2 417 080 | 0,07 | 43,40 | 69 440 | 104 901 272 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 415 480 | 0,01 | 43,32 | 12 994 | 104 626 516 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 224 | 2 415 180 | 0,09 | 43,23 | 96 144 | 104 408 231 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 217 | 2 412 956 | 0,13 | 43,12 | 138 733 | 104 058 728 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 18 961 | 2 409 739 | 0,79 | 43,28 | 820 632 | 104 293 504 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 575 | 2 390 778 | 0,32 | 43,22 | 327 354 | 103 317 471 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 875 | 2 383 203 | 0,33 | 43,20 | 340 161 | 102 942 454 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 15 775 | 2 375 328 | 0,67 | 43,20 | 681 480 | 102 614 170 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 200 | 2 359 553 | 0,14 | 43,31 | 138 592 | 102 192 240 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 131 | 2 356 353 | 0,22 | 43,14 | 221 326 | 101 641 287 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 656 | 2 351 222 | 0,03 | 43,34 | 28 431 | 101 901 961 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 800 | 2 350 566 | 0,25 | 43,08 | 249 835 | 101 250 630 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 952 | 2 344 766 | 0,17 | 43,17 | 170 608 | 101 223 548 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 237 | 2 340 814 | 0,01 | 43,33 | 10 269 | 101 427 471 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 601 | 2 340 577 | 0,41 | 43,08 | 413 659 | 100 843 760 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 719 | 2 330 976 | 0,29 | 43,28 | 290 832 | 100 896 296 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 701 | 2 324 257 | 0,42 | 43,30 | 420 005 | 100 628 707 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 53 392 | 2 314 556 | 2,36 | 43,10 | 2 301 195 | 99 757 364 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 900 | 2 261 164 | 0,35 | 43,21 | 341 359 | 97 704 896 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 253 264 | 0,01 | 43,23 | 8 646 | 97 414 236 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −550 000 | 0 | −100,00 | 25,25 | −13 885 355 | ||
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 253 064 | 0,00 | 43,17 | 4 317 | 97 270 406 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 10 499 | 2 252 964 | 0,47 | 43,10 | 452 559 | 97 114 013 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 23 598 | 2 242 465 | 1,06 | 43,28 | 1 021 203 | 97 042 673 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 14 802 | 2 218 867 | 0,67 | 43,26 | 640 335 | 95 988 186 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 575 | 2 204 065 | 0,30 | 43,24 | 284 336 | 95 314 791 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 25 400 | 2 197 490 | 1,17 | 43,09 | 1 094 486 | 94 689 844 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 10 300 | 2 172 090 | 0,48 | 43,07 | 443 621 | 93 551 916 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 161 790 | 0,01 | 43,34 | 8 667 | 93 681 170 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 161 590 | 0,00 | 43,27 | 4 327 | 93 537 403 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 758 | 2 161 490 | 0,31 | 43,25 | 292 284 | 93 484 442 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 198 | 2 154 732 | 0,43 | 43,26 | 397 951 | 93 224 480 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 100 | 2 145 534 | 0,43 | 43,24 | 393 438 | 92 762 162 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 136 434 | 0,00 | 43,15 | 4 315 | 92 192 468 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 504 | 2 136 334 | 0,16 | 43,22 | 151 460 | 92 343 037 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 080 | 2 132 830 | 0,33 | 43,18 | 305 714 | 92 095 599 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 900 | 2 125 750 | 0,09 | 43,12 | 81 918 | 91 651 711 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 123 850 | 0,00 | 43,32 | 4 332 | 92 005 182 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 8 700 | 2 123 750 | 0,41 | 43,15 | 375 405 | 91 639 812 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 100 | 2 115 050 | 0,10 | 43,16 | 90 636 | 91 285 558 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 800 | 2 112 950 | 0,09 | 43,18 | 77 733 | 91 247 746 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 220 | 2 111 150 | 0,15 | 43,14 | 138 927 | 91 085 567 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 12 600 | 2 107 930 | 0,60 | 43,19 | 544 194 | 91 041 497 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 35 664 | 2 095 330 | 1,73 | 43,08 | 1 536 405 | 90 266 816 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 800 | 2 059 666 | 0,18 | 43,24 | 164 312 | 89 059 958 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 055 866 | 0,01 | 43,06 | 12 920 | 88 535 869 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 300 | 2 055 566 | 0,36 | 43,14 | 314 922 | 88 677 117 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 20 602 | 2 048 266 | 1,02 | 43,22 | 890 418 | 88 526 057 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 13 500 | 2 027 664 | 0,67 | 43,29 | 584 415 | 87 777 575 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 647 | 2 014 164 | 0,18 | 43,16 | 157 386 | 86 921 247 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 550 000 | 2 010 517 | 37,66 | 25,25 | 13 885 355 | 50 757 713 | |
2016-07-05 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 567 | 5 095 | 12,52 | 74,91 | 42 474 | 381 666 | |
2016-04-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 554 | 4 479 | 14,11 | 76,69 | 42 486 | 343 495 | |
2016-03-09 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 672 | 5 977 | 38,84 | ||||
2016-03-03 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −653 | 4 305 | −13,17 | 69,07 | −45 103 | 297 346 | |
2016-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −70 354 | 1 460 517 | −4,60 | 39,52 | −2 780 390 | 57 719 632 | |
2016-02-23 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 1 198 630 | 1 198 630 | |||||
2016-02-23 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 136 718 | 1 530 871 | 9,81 | ||||
2016-01-05 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 310 | 3 880 | 8,68 | 68,52 | 21 241 | 265 858 | |
2016-01-05 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 185 | 10 772 | 12,36 | 118,14 | 140 001 | 1 272 569 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −438 000 | 0 | −100,00 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 900 | 1 394 153 | −0,14 | 46,05 | −87 495 | 64 200 746 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 396 053 | −0,02 | 46,04 | −13 814 | 64 281 260 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 1 396 353 | −0,09 | 46,04 | −59 852 | 64 288 092 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 100 | 1 397 653 | −0,08 | 46,04 | −50 638 | 64 340 956 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 439 | 1 398 753 | −1,02 | 46,03 | −664 627 | 64 384 601 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 413 192 | −0,01 | 46,03 | −9 206 | 65 045 695 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 617 | 1 413 392 | −0,18 | 46,02 | −120 447 | 65 051 367 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 150 | 1 416 009 | −0,85 | 46,02 | −559 143 | 65 164 734 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 921 | 1 428 159 | −0,20 | 46,02 | −134 410 | 65 716 736 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −89 114 | 1 431 080 | −5,86 | 46,01 | −4 100 135 | 65 843 991 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 1 520 194 | −0,03 | 46,01 | −18 403 | 69 940 325 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 781 | 1 520 594 | −0,96 | 46,00 | −680 000 | 69 954 927 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −296 778 | 1 535 375 | −16,20 | 46,00 | −13 651 788 | 70 627 250 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 438 000 | 1 832 153 | 31,42 | 21,22 | 9 294 097 | 38 877 187 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 280 | 8 832 | 3,27 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 175 | 8 818 | 2,02 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −630 | 0 | −100,00 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 300 | 8 552 | 3,64 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 300 | 8 552 | 3,64 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 630 | 630 | |||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −76 280 | 1 394 153 | −5,19 | ||||
2015-10-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 327 | 3 531 | 10,21 | 64,90 | 21 222 | 229 162 | |
2015-07-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 248 | 3 172 | 8,48 | 85,53 | 21 211 | 271 301 | |
2015-04-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 176 | 2 900 | 6,46 | 80,23 | 14 120 | 232 667 | |
2015-03-04 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −563 | 4 958 | −10,20 | ||||
2015-03-04 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 506 | 5 521 | 37,51 | ||||
2015-03-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −75 630 | 1 470 433 | −4,89 | 47,61 | −3 600 744 | 70 007 315 | |
2015-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 937 031 | 937 031 | |||||
2015-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 132 978 | 1 546 063 | 9,41 | ||||
2015-02-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 88 | 2 702 | 3,37 | 80,12 | 7 051 | 216 484 | |
2015-01-05 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 77 | 2 614 | 3,04 | 92,51 | 7 123 | 241 821 | |
2015-01-05 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 494 | 9 268 | 19,22 | 93,70 | 140 000 | 868 379 | |
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 185 | 8 252 | 2,29 | ||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 185 | 35 316 | 0,53 | ||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −555 | 0 | −100,00 | ||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 555 | 555 | |||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 295 | 8 067 | 3,80 | ||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 295 | 8 067 | 3,80 | ||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 440 | 1 413 085 | −0,10 | ||||
2014-12-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 69 | 2 537 | 2,80 | 102,36 | 7 063 | 259 700 | |
2014-11-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 70 | 2 451 | 2,94 | 101,60 | 7 112 | 249 034 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −38 034 | 0 | −100,00 | ||||
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −38 034 | 1 414 525 | −2,62 | 42,70 | −1 624 052 | 60 400 218 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 38 034 | 1 452 559 | 2,69 | 22,27 | 846 903 | 32 344 131 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −402 766 | 35 876 | −91,82 | ||||
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −384 107 | 1 414 525 | −21,36 | 42,50 | −16 324 548 | 60 117 312 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 700 | 1 798 632 | −0,32 | 42,50 | −242 264 | 76 446 357 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 959 | 1 804 332 | −0,71 | 42,50 | −550 822 | 76 693 132 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 402 766 | 1 817 291 | 28,47 | 22,27 | 8 968 391 | 40 465 619 | |
2014-10-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 71 | 2 381 | 3,07 | 99,45 | 7 061 | 236 790 | |
2014-09-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 65 | 2 310 | 2,90 | 108,68 | 7 064 | 251 039 | |
2014-08-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 70 | 2 231 | 3,24 | ||||
2014-07-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 65 | 2 161 | 3,10 | ||||
2014-06-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 69 | 2 096 | 3,40 | ||||
2014-05-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 67 | 2 015 | 3,44 | ||||
2014-04-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 70 | 1 948 | 3,73 | ||||
2014-03-05 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −498 | 4 015 | −11,03 | 96,31 | −47 962 | 386 685 | |
2014-03-04 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 298 | 4 513 | 40,37 | ||||
2014-03-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 73 | 1 878 | 4,04 | ||||
2014-03-04 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −91 882 | 1 414 525 | −6,10 | 39,79 | −3 655 985 | 56 283 950 | |
2014-02-25 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 727 699 | 727 699 | |||||
2014-02-25 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 118 865 | 1 506 407 | 8,57 | ||||
2014-02-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 76 | 1 794 | 4,42 | ||||
2014-01-16 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 443 | 7 511 | 23,78 | 97,03 | 140 000 | 728 751 | |
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 220 | 7 772 | 2,91 | ||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 220 | 7 772 | 2,91 | ||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −660 | 0 | −100,00 | ||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 660 | 660 | |||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 350 | 7 552 | 4,86 | ||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 350 | 7 552 | 4,86 | ||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 710 | 1 387 542 | −0,12 | ||||
2014-01-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 69 | 1 718 | 4,18 | ||||
2013-12-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 74 | 1 649 | 4,70 | ||||
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 1 389 252 | −0,04 | 38,36 | −23 016 | 53 291 707 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 000 | 1 389 852 | −0,07 | 38,35 | −38 350 | 53 300 824 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 1 390 852 | −0,20 | 38,34 | −107 352 | 53 325 266 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 393 652 | −0,01 | 38,31 | −3 831 | 53 390 808 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 393 752 | −0,02 | 38,30 | −11 492 | 53 387 670 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 394 052 | −0,02 | 38,30 | −11 490 | 53 392 192 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 183 | 1 394 352 | −0,23 | 38,29 | −121 877 | 53 389 738 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −9 888 | 1 397 535 | −0,70 | 38,27 | −378 414 | 53 483 664 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 100 | 1 407 423 | −0,29 | 38,26 | −156 886 | 53 855 041 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −48 095 | 1 411 523 | −3,30 | 38,26 | −1 840 115 | 54 004 870 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −54 900 | 1 459 618 | −3,62 | 38,26 | −2 100 200 | 55 837 687 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 400 | 1 514 518 | −0,55 | 38,25 | −321 300 | 57 930 314 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −11 200 | 1 522 918 | −0,73 | 38,24 | −428 344 | 58 243 999 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 108 | 1 534 118 | −0,14 | 38,23 | −80 589 | 58 649 331 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 1 536 226 | −0,04 | 38,22 | −22 935 | 58 722 239 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 300 | 1 536 826 | −0,15 | 38,22 | −87 906 | 58 737 490 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −300 401 | 0 | −100,00 | ||||
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 500 | 1 539 126 | −0,16 | 38,22 | −95 538 | 58 817 700 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 907 | 1 541 626 | −0,38 | 38,21 | −225 706 | 58 905 529 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 200 | 1 547 533 | −0,27 | 38,20 | −160 461 | 59 123 498 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 800 | 1 551 733 | −0,44 | 38,20 | −259 760 | 59 276 201 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 1 558 533 | −0,08 | 38,20 | −49 654 | 59 528 168 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 510 | 1 559 833 | −0,29 | 38,19 | −172 237 | 59 570 022 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 1 564 343 | −0,04 | 38,18 | −26 730 | 59 734 437 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 1 565 043 | −0,18 | 38,18 | −106 904 | 59 753 342 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 500 | 1 567 843 | −0,10 | 38,16 | −57 240 | 59 828 889 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 400 | 1 569 343 | −0,34 | 38,16 | −206 037 | 59 878 282 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 147 | 1 574 743 | −0,51 | 38,15 | −310 808 | 60 076 445 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −9 100 | 1 582 890 | −0,57 | 38,14 | −347 120 | 60 379 339 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 200 | 1 591 990 | −0,39 | 38,14 | −236 468 | 60 718 499 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 000 | 1 598 190 | −0,12 | 38,14 | −76 270 | 60 946 976 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 600 190 | −0,01 | 38,13 | −7 626 | 61 015 245 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 800 | 1 600 390 | −0,30 | 38,12 | −183 000 | 61 014 869 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 100 | 1 605 190 | −0,19 | 38,12 | −118 172 | 61 189 843 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 800 | 1 608 290 | −0,30 | 38,12 | −182 952 | 61 299 973 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −9 100 | 1 613 090 | −0,56 | 38,10 | −346 756 | 61 466 794 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 763 | 1 622 190 | −0,84 | 38,10 | −524 370 | 61 805 439 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 200 | 1 635 953 | −0,13 | 38,10 | −83 809 | 62 321 630 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 300 | 1 638 153 | −0,26 | 38,09 | −163 787 | 62 397 248 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 1 642 453 | −0,04 | 38,09 | −26 661 | 62 556 929 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 400 | 1 643 153 | −0,15 | 38,08 | −91 404 | 62 579 482 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 200 | 1 645 553 | −0,62 | 38,08 | −388 416 | 62 662 658 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 300 | 1 655 753 | −0,62 | 38,08 | −392 172 | 63 042 795 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 000 | 1 666 053 | −0,72 | 38,07 | −456 840 | 63 426 638 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 800 | 1 678 053 | −0,52 | 38,06 | −334 972 | 63 875 087 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 1 686 853 | −0,17 | 38,06 | −106 568 | 64 201 625 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 300 401 | 1 689 653 | 21,62 | 33,37 | 10 024 381 | 56 383 721 | |
2013-11-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 75 | 1 565 | 5,03 | ||||
2013-10-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 75 | 1 490 | 5,30 | ||||
2013-09-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 76 | 1 415 | 5,68 | ||||
2013-08-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 75 | 1 329 | 5,98 | ||||
2013-07-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 75 | 1 254 | 6,36 | ||||
2013-06-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 72 | 1 179 | 6,50 | ||||
2013-05-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 74 | 1 100 | 7,21 | ||||
2013-04-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 72 | 1 026 | 7,55 | ||||
2013-03-06 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −406 | 3 215 | −11,21 | 90,64 | −36 798 | 291 392 | |
2013-03-06 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 115 | 3 621 | 44,49 | ||||
2013-03-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 67 | 954 | 7,55 | ||||
2013-03-01 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −90 318 | 1 389 252 | −6,10 | 34,26 | −3 094 295 | 47 595 774 | |
2013-02-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 980 000 | 980 000 | |||||
2013-02-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 210 000 | 1 479 570 | 16,54 | ||||
2013-02-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 64 | 887 | 7,78 | ||||
2013-01-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 300 401 | 300 401 | |||||
2013-01-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −346 704 | 0 | −100,00 | ||||
2013-01-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −300 401 | 1 269 570 | −19,13 | 33,37 | −10 024 381 | 42 365 551 | |
2013-01-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 346 704 | 1 569 971 | 28,34 | 25,76 | 8 929 535 | 40 435 388 | |
2013-01-03 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 587 | 5 878 | 36,99 | 88,21 | 140 000 | 518 509 | |
2013-01-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 71 | 823 | 9,44 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 366 | 7 202 | 5,35 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −183 | 0 | −100,00 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −183 | 0 | −100,00 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −385 | 1 223 450 | −0,03 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 366 | 7 293 | 5,28 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −366 | 183 | −66,67 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 549 | 549 | |||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −15 921 | 1 223 835 | −1,28 | ||||
2012-12-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 77 | 748 | 11,48 | ||||
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 1 239 756 | −0,05 | 65,88 | −39 528 | 81 675 125 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 240 356 | −0,02 | 65,83 | −13 166 | 81 652 635 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 1 240 556 | −0,11 | 65,82 | −92 148 | 81 653 396 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 241 956 | −0,01 | 65,82 | −6 582 | 81 739 334 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 1 242 056 | −0,10 | 65,81 | −85 553 | 81 739 705 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 243 356 | −0,02 | 65,80 | −13 160 | 81 812 825 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 357 | 1 243 556 | −1,06 | 65,78 | −878 623 | 81 801 114 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −747 | 1 256 913 | −0,06 | 65,77 | −49 130 | 82 667 168 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −153 | 1 257 660 | −0,01 | 65,76 | −10 061 | 82 703 722 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 1 257 813 | −0,05 | 65,75 | −39 450 | 82 701 205 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 197 | 1 258 413 | −0,10 | 65,74 | −78 691 | 82 728 071 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 1 259 610 | −0,06 | 65,73 | −46 011 | 82 794 165 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 1 260 310 | −0,11 | 65,72 | −92 008 | 82 827 573 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 600 | 1 261 710 | −0,28 | 65,71 | −236 556 | 82 906 964 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 265 310 | −0,02 | 65,70 | −19 710 | 83 130 867 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 1 265 610 | −0,04 | 65,68 | −32 840 | 83 125 265 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 266 110 | −0,01 | 65,67 | −6 567 | 83 145 444 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 280 | 1 266 210 | −0,10 | 65,66 | −84 045 | 83 139 349 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 822 | 1 267 490 | −0,14 | 65,65 | −119 614 | 83 210 718 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 269 312 | −0,02 | 65,64 | −13 129 | 83 323 986 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 518 | 1 269 512 | −0,51 | 65,64 | −427 842 | 83 330 768 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 1 276 030 | −0,04 | 65,64 | −32 818 | 83 752 229 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 592 | 1 276 530 | −1,13 | 65,63 | −957 673 | 83 778 664 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 291 122 | −0,02 | 65,63 | −19 688 | 84 731 172 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 300 | 1 291 422 | −0,18 | 65,62 | −150 938 | 84 749 569 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −21 156 | 1 293 722 | −1,61 | 65,62 | −1 388 257 | 84 894 038 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 314 878 | −0,01 | 65,62 | −6 562 | 86 279 665 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 314 978 | −0,01 | 65,62 | −6 562 | 86 285 569 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 600 | 1 315 078 | −0,35 | 65,62 | −301 829 | 86 288 843 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −15 103 | 1 319 678 | −1,13 | 65,61 | −990 908 | 86 584 074 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 239 | 1 334 781 | −0,09 | 65,60 | −81 285 | 87 568 308 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 982 | 1 336 020 | −0,67 | 65,60 | −589 219 | 87 642 912 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 924 | 1 345 002 | −0,14 | 65,60 | −126 205 | 88 225 406 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −25 718 | 1 346 926 | −1,87 | 65,59 | −1 686 844 | 88 344 876 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 372 644 | −0,01 | 65,59 | −6 559 | 90 030 347 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 1 372 744 | −0,03 | 65,59 | −26 235 | 90 035 533 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 200 | 1 373 144 | −0,45 | 65,58 | −406 627 | 90 057 649 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −178 002 | 0 | −100,00 | ||||
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −1 890 | 0 | −100,00 | ||||
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −262 464 | 0 | −100,00 | ||||
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −70 956 | 0 | −100,00 | ||||
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 379 344 | −0,01 | 65,58 | −6 558 | 90 462 897 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 500 | 1 379 444 | −0,47 | 65,58 | −426 270 | 90 463 938 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 300 | 1 385 944 | −0,17 | 65,58 | −150 822 | 90 883 278 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −18 246 | 1 388 244 | −1,30 | 65,57 | −1 196 390 | 91 027 159 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 952 | 1 406 490 | −0,98 | 65,56 | −914 693 | 92 209 484 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 651 | 1 420 442 | −0,26 | 65,56 | −239 341 | 93 117 075 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −31 069 | 1 424 093 | −2,14 | 65,55 | −2 036 573 | 93 349 296 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 455 162 | −0,01 | 65,55 | −6 555 | 95 384 414 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 455 262 | −0,02 | 65,55 | −19 664 | 95 388 786 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 600 | 1 455 562 | −0,45 | 65,54 | −432 597 | 95 404 811 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −31 032 | 1 462 162 | −2,08 | 65,54 | −2 033 837 | 95 830 097 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 493 194 | −0,02 | 65,54 | −19 662 | 97 862 442 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 493 494 | −0,01 | 65,54 | −6 554 | 97 879 863 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 493 594 | −0,01 | 65,54 | −6 554 | 97 885 670 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 300 | 1 493 694 | −0,42 | 65,54 | −412 870 | 97 889 236 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −34 230 | 1 499 994 | −2,23 | 65,53 | −2 243 092 | 98 294 607 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 1 534 224 | −0,05 | 65,53 | −45 870 | 100 536 164 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 534 924 | −0,01 | 65,53 | −13 106 | 100 579 732 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 500 | 1 535 124 | −0,49 | 65,52 | −491 438 | 100 589 000 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −35 920 | 1 542 624 | −2,28 | 65,52 | −2 353 478 | 101 072 724 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 1 578 544 | −0,03 | 65,52 | −26 207 | 103 422 257 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 900 | 1 578 944 | −0,44 | 65,52 | −452 054 | 103 444 516 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −39 418 | 1 585 844 | −2,43 | 65,51 | −2 582 273 | 103 888 640 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 625 262 | −0,02 | 65,51 | −19 653 | 106 469 288 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 326 | 1 625 562 | −0,51 | 65,50 | −545 395 | 106 482 439 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −119 180 | 1 633 888 | −6,80 | 65,50 | −7 806 290 | 107 019 664 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 178 002 | 1 753 068 | 11,30 | 59,03 | 10 507 458 | 103 483 604 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 1 890 | 1 575 066 | 0,12 | 53,60 | 101 304 | 84 423 538 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 262 464 | 1 573 176 | 20,02 | 52,55 | 13 792 483 | 82 670 399 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 70 956 | 1 310 712 | 5,72 | 47,10 | 3 342 028 | 61 734 535 | |
2012-11-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 73 | 671 | 12,21 | ||||
2012-10-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 73 | 598 | 13,90 | ||||
2012-09-05 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 75 | 525 | 16,67 | ||||
2012-08-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 73 | 450 | 19,36 | ||||
2012-07-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 74 | 377 | 24,42 | ||||
2012-06-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 73 | 303 | 31,74 | ||||
2012-05-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 61 | 230 | 36,09 | ||||
2012-04-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 59 | 169 | 53,64 | ||||
2012-03-09 |
|
4 | CAT |
CATERPILLAR INC
Common |
F - Taxes | −392 | 2 497 | −13,57 | 107,47 | −42 128 | 268 353 | |
2012-03-07 |
|
4 | CAT |
CATERPILLAR INC
Common |
A - Award | 909 | 2 889 | 45,91 | ||||
2012-03-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 54 | 110 | 96,43 | ||||
2012-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −88 360 | 1 239 756 | −6,65 | 57,04 | −5 040 054 | 70 715 682 | |
2012-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 302 500 | 302 500 | |||||
2012-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 167 600 | 1 328 116 | 14,44 | ||||
2012-02-01 |
|
4 | CAT |
CATERPILLAR INC
Common |
A - Award | 56 | 56 | |||||
2012-01-04 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 296 | 4 161 | 45,23 | 100,33 | 130 000 | 417 441 | |
2009-05-14 |
|
4 | MCD |
MCDONALDS CORP
Common Stock |
P - Purchase | 5 000 | 5 000 | 53,97 | 269 850 | 269 850 | ||
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −8 390 | 762 300 | −1,09 | 44,15 | −370 418 | 33 655 545 | |
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 438 000 | 438 000 | |||||
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 139 000 | 770 690 | 22,00 | 44,16 | 6 138 240 | 34 033 670 | |
2005-10-04 | 3 | MOT |
MOTOROLA INC
Motorola, Inc. - Common Stock |
2 000 |